Free Trial

Jushi Holdings Inc. (OTCMKTS:JUSHF) Sees Large Growth in Short Interest

Jushi logo with Medical background

Key Points

  • Jushi Holdings Inc. experienced a significant increase in short interest of 5,600.0% in August, rising from 300 shares to 17,100 shares as of August 15th.
  • In mid-day trading, Jushi's stock price fell to $0.75, with a 12-month range between $0.22 and $0.98.
  • For the most recent quarter, Jushi reported earnings per share of ($0.06) and revenue of $65.05 million, slightly surpassing analyst expectations.
  • Five stocks we like better than Jushi.

Jushi Holdings Inc. (OTCMKTS:JUSHF - Get Free Report) was the target of a large growth in short interest in August. As of August 15th, there was short interest totaling 17,100 shares, agrowthof5,600.0% from the July 31st total of 300 shares. Based on an average daily trading volume, of 1,706,100 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily trading volume, of 1,706,100 shares, the days-to-cover ratio is presently 0.0 days.

Jushi Price Performance

JUSHF stock traded up $0.04 during mid-day trading on Friday, reaching $0.72. 107,923 shares of the company traded hands, compared to its average volume of 607,047. The company has a market capitalization of $142.59 million, a P/E ratio of -2.50 and a beta of -0.96. Jushi has a 52-week low of $0.22 and a 52-week high of $0.98. The company has a fifty day moving average price of $0.56 and a 200-day moving average price of $0.40.

Jushi (OTCMKTS:JUSHF - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported ($0.06) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.06). The company had revenue of $65.05 million for the quarter, compared to analysts' expectations of $64.67 million. As a group, analysts forecast that Jushi will post -0.23 EPS for the current year.

Jushi Company Profile

(Get Free Report)

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

Further Reading

Should You Invest $1,000 in Jushi Right Now?

Before you consider Jushi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.

While Jushi currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.